Imfinzi 00310-4611-50
Generic: Durvalumab
- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2017
- Listing Expires
- December 31, 2026
- Application
- BLA761069
Need to source Imfinzi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Durvalumab | 500 mg/10mL |
Drug Class
Programmed Death Ligand-1 Blocker [EPC]AntibodiesMonoclonal [CS]
Selected Package
00310-4611-50Selected1 VIAL in 1 CARTON (0310-4611-50) / 10 mL in 1 VIAL